Email this article 
Adverse events of modern antifungal drugs during treatment of invasive fungal infections
- Authors: Dmitrieva N.V.1, Petukhova I.N.1
-
Affiliations:
- N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences
- Issue: Vol 8, No 2 (2013)
- Pages: 47-60
- Section: PHARMACOTHERAPY
- Published: 22.05.2013
- URL: https://oncohematology.abvpress.ru/ongm/article/view/34
- DOI: https://doi.org/10.17650/1818-8346-2013-8-2-47-60
- ID: 34
Cite item
Full Text
Abstract
Characteristics of adverse events of modern antimycotics by organ systems and comparative frequency between different medicines and their groups are presented. The examples of incompatibility of antifungal drugs with other pharmacological groups are discussed. Records of adverse events and drug compatibility will allow the practitioner to prevent and timely cure possible complications, should they arise.
Keywords
About the authors
N. V. Dmitrieva
N.N. Blokhin Russian Cancer Research Center,Russian Academy of Medical Sciences
Laboratory for Microbiologic Diagnosis and Treatment of Infections in Oncology Russian Federation
I. N. Petukhova
N.N. Blokhin Russian Cancer Research Center,Russian Academy of Medical Sciences
Author for correspondence.
Email: irinapet@list.ru
Laboratory for Microbiologic Diagnosis and Treatment of Infections in Oncology Russian Federation
References
Supplementary files
